These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11166070)

  • 21. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
    Chartoff EH; Heusner CL; Palmiter RD
    Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E; Mele A; Oliverio A; Pert A
    Neuroscience; 2001; 104(1):105-16. PubMed ID: 11311535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.
    Powell KR; Holtzman SG
    Pharmacol Biochem Behav; 1998 Feb; 59(2):433-8. PubMed ID: 9476992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate.
    Blacker D; Broberger C; Ogren SO; Hökfelt T
    Neuroscience; 1997 Feb; 76(4):1057-67. PubMed ID: 9027866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
    de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice.
    Liljequist S
    Psychopharmacology (Berl); 1991; 104(1):17-21. PubMed ID: 1831907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat.
    Classey JD; Knight YE; Goadsby PJ
    Brain Res; 2001 Jul; 907(1-2):117-24. PubMed ID: 11430892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMDA-receptor modulation of lateral inhibition and c-fos expression in olfactory bulb.
    Wilson DA; Sullivan RM; Gall CM; Guthrie KM
    Brain Res; 1996 May; 719(1-2):62-71. PubMed ID: 8782864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists.
    López-Gil X; Jiménez-Sánchez L; Romón T; Campa L; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):945-56. PubMed ID: 21733285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.
    Lindén A; Storvik M; Lakso M; Haapasalo A; Lee D; Witkin JM; Sei Y; Castrén E; Wong G
    Neuropharmacology; 2001 Mar; 40(4):469-81. PubMed ID: 11249956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]MK-801 binding in various brain regions of rat lines selected for differential alcohol sensitivity.
    Näkki R; Wong G; Korpi ER
    Alcohol; 1995; 12(4):335-40. PubMed ID: 7546329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ethanol, MK-801, and chlordiazepoxide on locomotor activity in different rat lines: dissociation of locomotor stimulation from ethanol preference.
    Criswell HE; Overstreet DH; Rezvani AH; Johnson KB; Simson PE; Knapp DJ; Moy SS; Breese GR
    Alcohol Clin Exp Res; 1994 Aug; 18(4):917-23. PubMed ID: 7978104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of NMDA receptor antagonist MK-801 on light-induced Fos expression in the suprachiasmatic nuclei and on melatonin production in the Syrian hamster.
    Vuillez P; Jacob N; Teclemariam-Mesbah R; Van Rossum A; Vivien-Roels B; Pévet P
    J Neuroendocrinol; 1998 Sep; 10(9):671-7. PubMed ID: 9744484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex.
    Traub RJ; Zhai Q; Ji Y; Kovalenko M
    Neuroscience; 2002; 113(1):205-11. PubMed ID: 12123698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in NMDA receptor antagonist-induced locomotor activity and [3H]MK-801 binding sites in short-sleep and long-sleep mice.
    Velardo MJ; Simpson VJ; Zahniser NR
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1509-15. PubMed ID: 9802536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.